Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2005; 11(18): 2744-2747
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2744
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2744
Table 1 pBcl-2 and pBax expression and their relationship with clinicopathological parameters for the patients with pancreatic cancer.
| Parameter | No. of patients | Number of pBcl-2 and pBax expressing (%) | ||||
| pBcl-2 (+) | pBcl-2 (-) | PBax (+) | PBax (-) | |||
| Overall | 59 | 21 (35.6) | 38 (64.4) | 29 (49.2) | 30 (50.8) | |
| Age (yr) | <65 | 47 | 17 (36.2) | 30 (63.8) | 26 (55.3) | 21 (44.7) |
| ≥65 | 12 | 4 (33.3) | 8 (66.7) | 3 (25) | 9 (75) | |
| Gender | Male | 38 | 14 (36.8) | 24 (63.2) | 18 (47.3) | 20 (52.7) |
| Female | 21 | 7 (33.3) | 14 (66.7) | 11 (52.4) | 10 (47.6) | |
| TNM stage | I | 4 | 1 (25) | 3 (75) | 3 (75) | 1 (25) |
| II | 8 | 5 (62.5) | 3 (37.5) | 4 (50) | 4 (50) | |
| III | 42 | 14 (33.3) | 28 (66.7) | 19 (45.2) | 23 (54.8) | |
| IV | 5 | 1 (20) | 4 (80) | 3 (60) | 2 (40) | |
| Grade | Well | 19 | 8 (42.1) | 11 (57.9) | 11 (57.9) | 8 (42.1) |
| Moderate | 21 | 8 (38.1) | 13 (61.9) | 8 (38.1) | 13 (61.9) | |
| Poor | 19 | 5 (26.3) | 14 (73.7) | 10 (52.6) | 9 (47.7) | |
- Citation: Dong M, Zhou JP, Zhang H, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(18): 2744-2747
- URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2744.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i18.2744